<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>COVID-19: Gastrointestinal symptoms and complications</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">COVID-19: Gastrointestinal symptoms and complications</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">COVID-19: Gastrointestinal symptoms and complications</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Haytham M Kaafarani, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin Weiser, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 07, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3319436094"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>In February 2020, the World Health Organization designated the disease COVID-19, which stands for "coronavirus disease 2019," a pandemic. The virus that causes COVID-19 is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</p><p>COVID-19 primarily manifests as a lung infection, with most symptomatic patients presenting with fever and respiratory symptoms. However, it has significant extrapulmonary complications affecting most organ systems, including the gastrointestinal tract. </p><p>This topic reviews the gastrointestinal manifestations and complications of COVID-19, including mesenteric ischemia, with a particular focus on the critically ill COVID-19 patient. Management of COVID-19 patients who have preexisting gastrointestinal or liver diseases can be found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/127965.html" rel="external">"COVID-19: Issues related to gastrointestinal disease in adults"</a> and  <a class="medical medical_review" href="/z/d/html/128410.html" rel="external">"COVID-19: Issues related to liver disease in adults"</a>.) </p><p>Perioperative management of patients with active or recent COVID-19 infection is discussed in another topic. (See  <a class="medical medical_review" href="/z/d/html/127481.html" rel="external">"COVID-19: Perioperative risk assessment, preoperative screening and testing, and timing of surgery after infection", section on 'Preoperative evaluation'</a>.)</p><p class="headingAnchor" id="H716935471"><span class="h1">COVID-19 GASTROINTESTINAL SYMPTOMS</span><span class="headingEndMark"> — </span>While most symptomatic COVID-19 patients present with fever, cough, shortness of breath, and/or loss of the sensation of taste and smell, up to one-third of patients present with gastrointestinal complaints. (See  <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">"COVID-19: Clinical features", section on 'Initial presentation'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>In an early meta-analysis of 60 studies comprising 4243 patients, the majority from China, the pooled prevalence of all gastrointestinal symptoms was 17.6 percent [<a href="#rid1">1</a>]. Anorexia was the most common presenting symptom (26.8 percent), followed by diarrhea (12.5 percent), nausea/vomiting (10.2 percent), and abdominal pain (9.2 percent) [<a href="#rid1">1</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent meta-analysis of more than 18,000 patients from around the world suggested that diarrhea was the most common (11.5 percent) gastrointestinal symptom, followed by nausea and vomiting (6.3 percent), then abdominal pain (2.3 percent) [<a href="#rid2">2</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the subset of patients with the most severe SARS-CoV-2 infection presenting as acute respiratory distress syndrome (ARDS) and requiring intensive care, diarrhea is reported upon initial hospital presentation in one-third of the patients and nausea or vomiting in one-fifth of the patients [<a href="#rid3">3</a>].</p><p></p><p>In most of these early studies, the inquiry into and reporting of gastrointestinal symptoms upon presentation was not systematic, and thus, these rates are likely an underestimate of the true incidence. </p><p class="headingAnchor" id="H808210930"><span class="h1">GASTROINTESTINAL COMPLICATIONS IN CRITICALLY ILL COVID-19 PATIENTS</span><span class="headingEndMark"> — </span>Patients with severe COVID-19 are at a particularly high risk for developing gastrointestinal complications. During their often prolonged hospitalization, 74 to 86 percent of critically ill patients with COVID-19 manifest gastrointestinal complications ranging from self-resolving transaminitis and feeding intolerance to life-threatening mesenteric ischemia [<a href="#rid3">3,4</a>]. </p><p class="headingAnchor" id="H100933365"><span class="h2">Acute liver injury and elevated transaminases</span><span class="headingEndMark"> — </span>Nearly two-thirds of patients with severe COVID-19 develop elevated liver transaminases [<a href="#rid5">5</a>], with reported mean aspartate aminotransferase (AST) and alanine aminotransferase (ALT) above 400 units per liter of serum [<a href="#rid3">3</a>]. The liver injury can progress to liver ischemia in rare instances. </p><p>The etiology of acute liver injury in COVID-19 patients remains unclear but is likely multifactorial. Several studies are suggesting that the degree of elevation of the transaminases is a marker of disease severity and an independent predictor of mortality [<a href="#rid6">6-8</a>].</p><p>The treatment of acute liver injury in COVID-19 patients is further discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/128410.html" rel="external">"COVID-19: Issues related to liver disease in adults", section on 'Management principles'</a>.)</p><p class="headingAnchor" id="H3846873430"><span class="h2">Acute cholecystitis</span><span class="headingEndMark"> — </span>Acute cholecystitis has been widely reported in patients with COVID-19, especially those who are critically ill [<a href="#rid3">3,4,9-13</a>]. In most patients, the cholecystitis is acalculous, and the etiology remains largely unclear. While hypomotility of the gallbladder wall is expected in critical illness in general, a direct viral involvement in the pathophysiology in COVID-19 patients cannot be ruled out [<a href="#rid13">13</a>]. (See <a class="local">'Possible etiologies of COVID-related gastrointestinal complications'</a> below.)</p><p>In critically ill COVID-19 patients, initial management of acute cholecystitis should be with antibiotics and percutaneous cholecystostomy rather than surgery [<a href="#rid14">14,15</a>]. Cholecystectomy is reserved for those who do not respond to percutaneous drainage [<a href="#rid13">13</a>]. In a study by the COVIDSurg Collaborative, an international collaborative of more than 6000 hospitals across more than 90 countries, 1128 COVID-19 patients who underwent surgery had a perioperative mortality as high as 24.8 percent [<a href="#rid16">16</a>]. Age greater than 70, male sex, emergency surgery, and cancer or major surgery independently predict mortality. </p><p>The treatment of acalculous cholecystitis is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/672.html" rel="external">"Acalculous cholecystitis: Clinical manifestations, diagnosis, and management", section on 'Management'</a>.)</p><p class="headingAnchor" id="H3202351875"><span class="h2">Acute pancreatitis</span><span class="headingEndMark"> — </span>Acute pancreatitis has also been widely reported in patients with COVID-19, especially in those with critical illness [<a href="#rid3">3,4,11,17-21</a>]. Progression to necrotizing pancreatitis that requires percutaneous, endoscopic, or surgical debridement has been also reported. </p><p>The hypothesis that acute pancreatitis in these cases is directly caused by SARS-CoV-2 is plausible, but the association between COVID-19 and acute pancreatitis is still not very well understood [<a href="#rid22">22</a>]. (See <a class="local">'Possible etiologies of COVID-related gastrointestinal complications'</a> below.)</p><p>Acute pancreatitis in COVID patients is managed in the same way as that in non-COVID patients. The treatment of acute pancreatitis is discussed in another topic. (See  <a class="medical medical_review" href="/z/d/html/5633.html" rel="external">"Management of acute pancreatitis"</a>.) </p><p class="headingAnchor" id="H3797000340"><span class="h2">Ileus and feeding intolerance</span><span class="headingEndMark"> — </span>In critically ill COVID-19 patients admitted to the intensive care unit (ICU), significant ileus and feeding intolerance occur in 46 to 56 percent [<a href="#rid3">3</a>]. </p><p>The etiology of the ileus is likely multifactorial, especially since these patients commonly require high doses of sedatives and opioids for ventilator synchrony, and these medications are associated with slowed intestinal function. However, the possibility of a SARS-CoV-2-specific etiology cannot be excluded. (See <a class="local">'Possible etiologies of COVID-related gastrointestinal complications'</a> below.)</p><p>The treatment of ileus is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/8042.html" rel="external">"Postoperative ileus", section on 'Management'</a>.)</p><p class="headingAnchor" id="H3115765140"><span class="h2">Acute colonic pseudo-obstruction</span><span class="headingEndMark"> — </span>Several cohort studies and case reports have reported a distinct colonic syndrome in the critically ill COVID-19 patient characterized by severe gaseous distention with no obvious distal obstruction, similar to the well-described acute colonic pseudo-obstruction, or Ogilvie's syndrome [<a href="#rid3">3,23,24</a>]. (See  <a class="medical medical_review" href="/z/d/html/2531.html" rel="external">"Acute colonic pseudo-obstruction (Ogilvie's syndrome)"</a>.)</p><p>The etiology of acute colonic pseudo-obstruction in critically ill COVID-19 patients, and whether it is COVID-19 specific or a simple manifestation of prolonged critical illness, remains unclear. Some authors have reported hemorrhagic colitis and ischemic colitis in COVID-19 patients [<a href="#rid25">25,26</a>]. Several others have reported microangiopathy and/or infectious colitis in pathologic examinations. (See <a class="local">'Possible etiologies of COVID-related gastrointestinal complications'</a> below.) </p><p>When colonic pseudo-obstruction is encountered in the ICU, and if the patient remains stable with no evidence of worsening sepsis or shock, we recommend conservative management with electrolyte optimization, colonic decompression with a rectal tube or endoscopically, and decreasing or discontinuing any medications that could be worsening the paralytic ileus (eg, opioids, sedatives). Whether there is a role for acetylcholinesterase inhibitors such as <a class="drug drug_general" data-topicid="9693" href="/z/d/drug information/9693.html" rel="external">neostigmine</a> is unclear. (See  <a class="medical medical_review" href="/z/d/html/2531.html" rel="external">"Acute colonic pseudo-obstruction (Ogilvie's syndrome)", section on 'Management'</a>.)</p><p>In a small number of patients, the colonic distention, especially if not mitigated, can progress to wall necrosis and perforation, thus requiring surgical intervention. Therefore, the clinician should maintain a high clinical index of suspicion for ischemia and perforation in case of worsening clinical status.</p><p class="headingAnchor" id="H266673890"><span class="h2">Mesenteric ischemia</span><span class="headingEndMark"> — </span>The most serious gastrointestinal complication reported in critically ill COVID-19 patients is mesenteric ischemia [<a href="#rid3">3,27-45</a>]. In cohort studies of critically ill COVID-19 patients admitted to a single institution, the incidence was reported at 3.8 to 4 percent [<a href="#rid3">3,27</a>]. </p><p>Because most of these patients are sedated, requiring mechanical ventilation, and on low doses of vasopressors precluding a reliable clinical evaluation [<a href="#rid28">28,29</a>], early diagnosis based on physical exam and classic symptomatology (eg, severe abdominal pain or tenderness) is often not feasible. Instead, new feeding intolerance in the ICU, abdominal distention, increasing leukocytosis, increasing vasopressor requirements, and/or unexplained metabolic acidosis are the most common presenting signs [<a href="#rid28">28-30</a>]. Elevated lactate levels are neither sensitive nor specific in diagnosing mesenteric ischemia in these patients; thus, clinicians should not exclude bowel ischemia solely on the basis of a normal lactate level. </p><p>Abdominopelvic computed tomography (CT) imaging can demonstrate bowel wall thickening, pneumatosis, and/or portal venous air [<a href="#rid46">46</a>]. When intravenous contrast is used, arterial phase imaging occasionally shows filling defects in the thoracoabdominal aorta or mesenteric arteries suggestive of acute thromboembolic phenomena [<a href="#rid30">30-33,47</a>]. In other patients, delayed venous phase imaging can show filling defects in the inferior vena cava or portomesenteric venous system [<a href="#rid30">30,33,34</a>]. However, a significant number of patients develop mesenteric ischemia despite patent and well-perfusing proximal and mesenteric vessels on CT [<a href="#rid3">3,27,28</a>], suggesting perhaps that the pathophysiology of thrombosis involves the small intestinal vessels. (See  <a class="medical medical_review" href="/z/d/html/91221.html" rel="external">"Nonocclusive mesenteric ischemia"</a>.)</p><p>Once mesenteric ischemia is suspected clinically and/or radiologically, operative intervention is often indicated for bowel examination and resection, if within the patient's goals of care [<a href="#rid27">27,35</a>]. When proximal arterial thromboembolic disease is suspected, endovascular or open angiography and thrombectomy is required. (See  <a class="medical medical_review" href="/z/d/html/96754.html" rel="external">"Acute mesenteric arterial occlusion", section on 'Management'</a>.)</p><p>On intraoperative examination of the bowel in these patients, many surgeons reported unusual findings with patchy areas of well-demarcated yellow discoloration involving the antimesenteric bowel wall  (<a class="graphic graphic_picture graphicRef131026" href="/z/d/graphic/131026.html" rel="external">picture 1</a>) [<a href="#rid3">3,27,28</a>]. The terminal ileum is the most commonly involved area of intestinal necrosis [<a href="#rid3">3,27-29</a>]. Occasionally, the bowel will appear pale or ischemic but not frankly necrotic. In those cases, leaving the abdomen temporarily open for a planned second-look laparotomy within 12 to 24 hours is recommended as ischemia can often quickly evolve into transmural necrosis. </p><p>The pathological examination of the resected bowel is reported to demonstrate extensive mucosal ulceration, congestion with areas of extensive transmural inflammation, and transmural infarction [<a href="#rid3">3</a>]. Fibrin microthrombi were occasionally noted in the capillaries underlying areas of necrosis, again raising the possibility of thrombosis at the submucosal vessel level [<a href="#rid27">27</a>]. </p><p>Despite these observations, the pathophysiology of bowel ischemia in these critically ill patients with COVID-19 remains uncertain. It is well established that patients who are admitted to the ICU can develop mesenteric ischemia simply due to high doses of vasopressors, hemodynamic instability, and metabolic derangements that compromise intestinal blood flow. While this may contribute to the high rate of bowel ischemia observed in patients with COVID-19, the atypical features of the mesenteric ischemia and the rare involvement of the watershed areas strongly suggest alternative mechanisms that are specific to COVID-19. (See <a class="local">'Possible etiologies of COVID-related gastrointestinal complications'</a> below.)</p><p>The mortality rate of COVID-19 patients who develop mesenteric ischemia is currently reported to be as high as 40 percent, with more than 92 percent of the deaths occurring within the immediate postoperative days due to multiorgan failure or refractory septic shock [<a href="#rid35">35</a>].</p><p class="headingAnchor" id="H1468864679"><span class="h1">POSSIBLE ETIOLOGIES OF COVID-RELATED GASTROINTESTINAL COMPLICATIONS</span><span class="headingEndMark"> — </span>It is likely that the high incidence of gastrointestinal complications in COVID-19 patients is not only a general manifestation of critical illness but is at least partially attributable to COVID-19 itself. </p><p>In a propensity score matched comparison of 184 patients with acute respiratory distress syndrome (ARDS), COVID-19 patients had double the rate of gastrointestinal complications compared with patients without COVID-19 (74 versus 37 percent), and the difference was more evident after the third hospitalization day  (<a class="graphic graphic_figure graphicRef131025" href="/z/d/graphic/131025.html" rel="external">figure 1</a>) [<a href="#rid48">48</a>]. Specifically, more patients with COVID-19 ARDS developed elevation of liver enzymes (55 versus 27 percent), ileus (48 versus 22 percent), or bowel ischemia (4 versus 0 percent) compared with equally ill but non-COVID patients [<a href="#rid48">48</a>]. </p><p>There is evidence that SARS-CoV-2 may be present in the gastrointestinal tract and that the angiotensin-converting enzyme 2 (ACE2) receptor is highly expressed throughout the gastrointestinal tract. As such, SARS-CoV-2 may enter gastrointestinal cells via ACE2 receptors to cause direct damage to the gastrointestinal organs. (See  <a class="medical medical_review" href="/z/d/html/126981.html" rel="external">"COVID-19: Epidemiology, virology, and prevention", section on 'Virology'</a>.)</p><p class="headingAnchor" id="H4233473437"><span class="h2">Evidence of SARS-CoV-2 in the gastrointestinal tract</span><span class="headingEndMark"> — </span>SARS-CoV-2 RNA has been detected by reverse-transcriptase polymerase chain reaction in multiple gastrointestinal sites.</p><p class="bulletIndent1"><span class="glyph">●</span>SARS-CoV-2 RNA has been detected in stool and gastrointestinal tissue samples of patients with COVID-19.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a study of 65 hospitalized patients with COVID-19, SARS-CoV-2 RNA was detected in the fecal samples from more than one-half of the patients with gastrointestinal symptoms and in nearly 40 percent of patients without any overt gastrointestinal symptoms [<a href="#rid49">49</a>]. Six patients with gastrointestinal symptoms underwent endoscopy and biopsy, and SARS-CoV-2 RNA was detected in the tissue samples from the esophagus, stomach, duodenum, colon, and rectum [<a href="#rid49">49</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a meta-analysis of 12 studies and 138 patients, the pooled prevalence of stool samples that were positive for the SARS-CoV-2 RNA was 48.1 percent. As importantly, more than 70 percent of the patients with positive stool samples had respiratory specimens that were negative for SARS-CoV-2 RNA, suggesting that the shedding of SARS-CoV-2 RNA in stool can significantly outlast the respiratory shedding, sometimes lingering for more than 30 days [<a href="#rid1">1</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>SARS-CoV-2 RNA has been detected in the gallbladder wall of a few COVID-19 patients who underwent cholecystectomy [<a href="#rid50">50</a>] and in the bile of another patient with COVID-19-related gallbladder disease [<a href="#rid51">51</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>SARS-CoV-2 RNA has been detected in the fluid from pancreatic pseudocysts of COVID-19 patients [<a href="#rid52">52</a>]. </p><p></p><p>It is less clear whether there is active SARS-CoV-2 replication in the gastrointestinal system or the viral RNA present in the gastrointestinal tract comes from swallowed respiratory viruses. On one hand, no live SARS-CoV-2 has been isolated from stool. On the other hand, the combination of very high concentrations of virus RNA and the occasional detection of cells in stools that contain subgenomic mRNA indicate active replication in the gastrointestinal tract [<a href="#rid53">53</a>]. Viral subgenomic mRNA is transcribed only in infected cells and is not packaged into virions and therefore indicates the presence of actively infected cells in samples. </p><p class="headingAnchor" id="H77326350"><span class="h2">ACE2 expression in the gastrointestinal tract</span><span class="headingEndMark"> — </span>One of the host receptors for SARS-CoV-2 cell entry is the ACE2 [<a href="#rid54">54</a>]. Both ACE2 mRNA and protein are highly expressed in the small intestine and colon, specifically at the enterocyte level [<a href="#rid55">55-57</a>]. ACE2 is also expressed in gallbladder epithelial cells and pancreatic ductal, acinar, and islet cells [<a href="#rid58">58,59</a>]. If there is active replication of SARS-CoV-2 in the gastrointestinal tract, such ACE2 receptor expression is likely one of the mechanisms that mediates the reported gastrointestinal symptoms and complications of COVID-19.</p><p class="headingAnchor" id="H2380575803"><span class="h2">Microvascular coagulopathy</span><span class="headingEndMark"> — </span>In COVID-19 patients, an inflammatory coagulopathy has been postulated to be associated with worse pulmonary disease, deep vein thrombosis, cerebrovascular accidents/strokes, and renal failure, and a similar mechanism may potentially contribute to mesenteric ischemia. However, there are insufficient data to recommend empiric therapeutic anticoagulation to prevent mesenteric ischemia in COVID-19 patients, even in those with elevated D-dimers. (See  <a class="medical medical_review" href="/z/d/html/127926.html" rel="external">"COVID-19: Hypercoagulability"</a>.)</p><p class="headingAnchor" id="H2510560348"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/126613.html" rel="external">"Society guideline links: COVID-19 – Index of guideline topics"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/130989.html" rel="external">"Society guideline links: COVID-19 – Surgical care"</a>.)</p><p class="headingAnchor" id="H483670798"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Extrapulmonary symptoms of COVID-19</strong> – Although COVID-19 primarily manifests as a lung infection, it has significant extrapulmonary complications affecting most organ systems, including the gastrointestinal tract. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>COVID-19 gastrointestinal symptoms</strong> – Up to one-third of patients with COVID-19 initially present with gastrointestinal rather than respiratory symptoms, most commonly anorexia, diarrhea, nausea or vomiting, and abdominal pain. (See <a class="local">'COVID-19 gastrointestinal symptoms'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastrointestinal complications in critically ill COVID-19 patients</strong> – About three-quarters of critically ill patients from COVID-19 develop gastrointestinal complications, which range from self-resolving transaminitis or intestinal/colonic ileus, to acute cholecystitis or pancreatitis, to life-threatening mesenteric ischemia. (See <a class="local">'Gastrointestinal complications in critically ill COVID-19 patients'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Possible etiologies of COVID-related gastrointestinal complications</strong> – While the pathophysiology of gastrointestinal complications in COVID-19 is likely multifactorial, it is at least partially COVID-19 specific, which may be potentially related to the virus, high levels of angiotensin-converting enzyme 2 (ACE2) receptor expression, and/or microvascular coagulopathy in the gastrointestinal tract. (See <a class="local">'Possible etiologies of COVID-related gastrointestinal complications'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Cheung KS, Hung IFN, Chan PPY, et al. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology 2020; 159:81.</a></li><li><a class="nounderline abstract_t">Silva FAFD, Brito BB, Santos MLC, et al. COVID-19 gastrointestinal manifestations: a systematic review. Rev Soc Bras Med Trop 2020; 53:e20200714.</a></li><li><a class="nounderline abstract_t">Kaafarani HMA, El Moheb M, Hwabejire JO, et al. Gastrointestinal Complications in Critically Ill Patients With COVID-19. Ann Surg 2020; 272:e61.</a></li><li><a class="nounderline abstract_t">Sun JK, Liu Y, Zou L, et al. Acute gastrointestinal injury in critically ill patients with COVID-19 in Wuhan, China. World J Gastroenterol 2020; 26:6087.</a></li><li><a class="nounderline abstract_t">Zhao X, Lei Z, Gao F, et al. The impact of coronavirus disease 2019 (COVID-19) on liver injury in China: A systematic review and meta-analysis. Medicine (Baltimore) 2021; 100:e24369.</a></li><li><a class="nounderline abstract_t">Phipps MM, Barraza LH, LaSota ED, et al. Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort. Hepatology 2020; 72:807.</a></li><li><a class="nounderline abstract_t">Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020; 5:428.</a></li><li><a class="nounderline abstract_t">Suresh Kumar VC, Harne PS, Mukherjee S, et al. Transaminitis is an indicator of mortality in patients with COVID-19: A retrospective cohort study. World J Hepatol 2020; 12:619.</a></li><li><a class="nounderline abstract_t">Scutari R, Piermatteo L, Ciancio Manuelli M, et al. Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis. Life (Basel) 2020; 10.</a></li><li><a class="nounderline abstract_t">Puig G, Giménez-Milà M, Campistol E, et al. Development of concomitant diseases in COVID-19 critically ill patients. Rev Esp Anestesiol Reanim (Engl Ed) 2021; 68:37.</a></li><li><a class="nounderline abstract_t">Hassani AH, Beheshti A, Almasi F, et al. Unusual gastrointestinal manifestations of COVID-19: two case reports. Gastroenterol Hepatol Bed Bench 2020; 13:410.</a></li><li><a class="nounderline abstract_t">Alhassan SM, Iqbal P, Fikrey L, et al. Post COVID 19 acute acalculous cholecystitis raising the possibility of underlying dysregulated immune response, a case report. Ann Med Surg (Lond) 2020; 60:434.</a></li><li><a class="nounderline abstract_t">Mattone E, Sofia M, Schembari E, et al. Acute acalculous cholecystitis on a COVID-19 patient: a case report. Ann Med Surg (Lond) 2020; 58:73.</a></li><li><a class="nounderline abstract_t">Ying M, Lu B, Pan J, et al. COVID-19 with acute cholecystitis: a case report. BMC Infect Dis 2020; 20:437.</a></li><li><a class="nounderline abstract_t">Çiyiltepe H, Yıldırım G, Fersahoğlu MM, et al. Clinical approach to patients admitted to the emergency room due to acute cholecystitis during the COVID-19 pandemic and percutaneous cholecystostomy experience. Ulus Travma Acil Cerrahi Derg 2021; 27:34.</a></li><li><a class="nounderline abstract_t">COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 2020; 396:27.</a></li><li><a class="nounderline abstract_t">Akkus C, Yilmaz H, Mizrak S, et al. Development of pancreatic injuries in the course of COVID-19. Acta Gastroenterol Belg 2020; 83:585.</a></li><li><a class="nounderline abstract_t">Suchman K, Raphael KL, Liu Y, et al. Acute pancreatitis in children hospitalized with COVID-19. Pancreatology 2021; 21:31.</a></li><li><a class="nounderline abstract_t">Rasch S, Herner A, Schmid RM, et al. High lipasemia is frequent in Covid-19 associated acute respiratory distress syndrome. Pancreatology 2021; 21:306.</a></li><li><a class="nounderline abstract_t">Miró Ò, Llorens P, Jiménez S, et al. A case-control emergency department-based analysis of acute pancreatitis in Covid-19: Results of the UMC-19-S6. J Hepatobiliary Pancreat Sci 2021; 28:953.</a></li><li><a class="nounderline abstract_t">Kandasamy S. An unusual presentation of COVID-19: Acute pancreatitis. Ann Hepatobiliary Pancreat Surg 2020; 24:539.</a></li><li><a class="nounderline abstract_t">de-Madaria E, Capurso G. COVID-19 and acute pancreatitis: examining the causality. Nat Rev Gastroenterol Hepatol 2021; 18:3.</a></li><li><a class="nounderline abstract_t">Ibrahim YS, Karuppasamy G, Parambil JV, et al. Case Report: Paralytic Ileus: A Potential Extrapulmonary Manifestation of Severe COVID-19. Am J Trop Med Hyg 2020; 103:1600.</a></li><li><a class="nounderline abstract_t">Sattar Y, Connerney M, Rauf H, et al. Three Cases of COVID-19 Disease With Colonic Manifestations. Am J Gastroenterol 2020; 115:948.</a></li><li><a class="nounderline abstract_t">Carvalho A, Alqusairi R, Adams A, et al. SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease. Am J Gastroenterol 2020; 115:942.</a></li><li><a class="nounderline abstract_t">Chan KH, Lim SL, Damati A, et al. Coronavirus disease 2019 (COVID-19) and ischemic colitis: An under-recognized complication. Am J Emerg Med 2020; 38:2758.e1.</a></li><li><a class="nounderline abstract_t">El Moheb M, Christensen MA, Naar L, et al. Comment on "Gastrointestinal Complications in Critically Ill Patients With COVID-19": An Update. Ann Surg 2021; 274:e821.</a></li><li><a class="nounderline abstract_t">Gartland RM, Velmahos GC. Bowel Necrosis in the Setting of COVID-19. J Gastrointest Surg 2020; 24:2888.</a></li><li><a class="nounderline abstract_t">Almafreji I, Ranganath S. Bowel Ischemia in a Patient With SARS CoV-2-Like Illness and Negative Real-Time Reverse Transcription Polymerase Chain Reaction Test Results During the Peak of the Pandemic. Cureus 2020; 12:e10442.</a></li><li><a class="nounderline abstract_t">de Barry O, Mekki A, Diffre C, et al. Arterial and venous abdominal thrombosis in a 79-year-old woman with COVID-19 pneumonia. Radiol Case Rep 2020; 15:1054.</a></li><li><a class="nounderline abstract_t">Rodriguez-Nakamura RM, Gonzalez-Calatayud M, Martinez Martinez AR. Acute mesenteric thrombosis in two patients with COVID-19. Two cases report and literature review. Int J Surg Case Rep 2020; 76:409.</a></li><li><a class="nounderline abstract_t">A Beccara L, Pacioni C, Ponton S, et al. Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection. Eur J Case Rep Intern Med 2020; 7:001690.</a></li><li><a class="nounderline abstract_t">Norsa L, Valle C, Morotti D, et al. Intestinal ischemia in the COVID-19 era. Dig Liver Dis 2020; 52:1090.</a></li><li><a class="nounderline abstract_t">Keshavarz P, Rafiee F, Kavandi H, et al. Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation. Clin Imaging 2021; 73:86.</a></li><li><a class="nounderline abstract_t">Thuluva SK, Zhu H, Tan MML, et al. A 29-Year-Old Male Construction Worker from India Who Presented with Left- Sided Abdominal Pain Due to Isolated Superior Mesenteric Vein Thrombosis Associated with SARS-CoV-2 Infection. Am J Case Rep 2020; 21:e926785.</a></li><li><a class="nounderline abstract_t">Seeliger B, Philouze G, Cherkaoui Z, et al. Acute abdomen in patients with SARS-CoV-2 infection or co-infection. Langenbecks Arch Surg 2020; 405:861.</a></li><li><a class="nounderline abstract_t">Singh B, Mechineni A, Kaur P, et al. Acute Intestinal Ischemia in a Patient with COVID-19 Infection. Korean J Gastroenterol 2020; 76:164.</a></li><li><a class="nounderline abstract_t">Bianco F, Ranieri AJ, Paterniti G, et al. Acute intestinal ischemia in a patient with COVID-19. Tech Coloproctol 2020; 24:1217.</a></li><li><a class="nounderline abstract_t">Almeida Vargas A, Valentí V, Sánchez Justicia C, et al. Severe colon ischemia in patients with severe coronavirus-19 (COVID-19). Rev Esp Enferm Dig 2020; 112:784.</a></li><li><a class="nounderline abstract_t">Besutti G, Bonacini R, Iotti V, et al. Abdominal Visceral Infarction in 3 Patients with COVID-19. Emerg Infect Dis 2020; 26:1926.</a></li><li><a class="nounderline abstract_t">Farina D, Rondi P, Botturi E, et al. Gastrointestinal: Bowel ischemia in a suspected coronavirus disease (COVID-19) patient. J Gastroenterol Hepatol 2021; 36:41.</a></li><li><a class="nounderline abstract_t">Paul T, Joy AR, Alsoub HARS, Parambil JV. Case Report: Ischemic Colitis in Severe COVID-19 Pneumonia: An Unforeseen Gastrointestinal Complication. Am J Trop Med Hyg 2021; 104:63.</a></li><li><a class="nounderline abstract_t">Gao Y, Xi H, Chen L. Emergency Surgery in Suspected COVID-19 Patients With Acute Abdomen: Case Series and Perspectives. Ann Surg 2020; 272:e38.</a></li><li><a class="nounderline abstract_t">Kielty J, Duggan WP, O'Dwyer M. Extensive pneumatosis intestinalis and portal venous gas mimicking mesenteric ischaemia in a patient with SARS-CoV-2. Ann R Coll Surg Engl 2020; 102:e145.</a></li><li><a class="nounderline abstract_t">Chiu CY, Sarwal A, Mon AM, et al. Gastrointestinal: COVID-19 related ischemic bowel disease. J Gastroenterol Hepatol 2021; 36:850.</a></li><li><a class="nounderline abstract_t">Bhayana R, Som A, Li MD, et al. Abdominal Imaging Findings in COVID-19: Preliminary Observations. Radiology 2020; 297:E207.</a></li><li><a class="nounderline abstract_t">Osilli D, Pavlovica J, Mane R, et al. Case reports: mild COVID-19 infection and acute arterial thrombosis. J Surg Case Rep 2020; 2020:rjaa343.</a></li><li><a class="nounderline abstract_t">El Moheb M, Naar L, Christensen MA, et al. Gastrointestinal Complications in Critically Ill Patients With and Without COVID-19. JAMA 2020; 324:1899.</a></li><li><a class="nounderline abstract_t">Lin L, Jiang X, Zhang Z, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 2020; 69:997.</a></li><li><a class="nounderline abstract_t">Balaphas A, Gkoufa K, Meyer J, et al. COVID-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall. J Hepatol 2020; 73:1566.</a></li><li><a class="nounderline abstract_t">Liao Y, Wang B, Wang J, et al. SARS-CoV-2 in the bile of a patient with COVID-19-associated gallbladder disease. Endoscopy 2020; 52:1148.</a></li><li><a class="nounderline abstract_t">Schepis T, Larghi A, Papa A, et al. SARS-CoV2 RNA detection in a pancreatic pseudocyst sample. Pancreatology 2020; 20:1011.</a></li><li><a class="nounderline abstract_t">Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581:465.</a></li><li><a class="nounderline abstract_t">Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270.</a></li><li><a class="nounderline abstract_t">Zhang H, Li HB, Lyu JR, et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis 2020; 96:19.</a></li><li><a class="nounderline abstract_t">Singh M, Bansal V, Feschotte C. A single-cell RNA expression map of human coronavirus entry factors. bioRxiv 2020.</a></li><li><a class="nounderline abstract_t">Ren P, Gong C, Ma S. Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients. Open Med (Wars) 2020; 15:613.</a></li><li><a class="nounderline abstract_t">Liu F, Long X, Zhang B, et al. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clin Gastroenterol Hepatol 2020; 18:2128.</a></li><li><a class="nounderline abstract_t">Hikmet F, Méar L, Edvinsson Å, et al. The protein expression profile of ACE2 in human tissues. Mol Syst Biol 2020; 16:e9610.</a></li></ol></div><div id="topicVersionRevision">Topic 129171 Version 7.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32251668" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33263693" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : COVID-19 gastrointestinal manifestations: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32675498" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Gastrointestinal Complications in Critically Ill Patients With COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33132657" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Acute gastrointestinal injury in critically ill patients with COVID-19 in Wuhan, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33530232" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The impact of coronavirus disease 2019 (COVID-19) on liver injury in China: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32473607" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32145190" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Liver injury in COVID-19: management and challenges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33033568" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Transaminitis is an indicator of mortality in patients with COVID-19: A retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33238410" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33246554" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Development of concomitant diseases in COVID-19 critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33244387" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Unusual gastrointestinal manifestations of COVID-19: two case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33224493" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Post COVID 19 acute acalculous cholecystitis raising the possibility of underlying dysregulated immune response, a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32895611" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Acute acalculous cholecystitis on a COVID-19 patient: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32571224" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : COVID-19 with acute cholecystitis: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33394479" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Clinical approach to patients admitted to the emergency room due to acute cholecystitis during the COVID-19 pandemic and percutaneous cholecystostomy experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32479829" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33321015" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Development of pancreatic injuries in the course of COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33309015" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Acute pancreatitis in children hospitalized with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33277183" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : High lipasemia is frequent in Covid-19 associated acute respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33259695" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A case-control emergency department-based analysis of acute pancreatitis in Covid-19: Results of the UMC-19-S6.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33234760" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : An unusual presentation of COVID-19: Acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33203968" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : COVID-19 and acute pancreatitis: examining the causality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32876011" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Case Report: Paralytic Ileus: A Potential Extrapulmonary Manifestation of Severe COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32427677" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Three Cases of COVID-19 Disease With Colonic Manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32496741" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32499176" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Coronavirus disease 2019 (COVID-19) and ischemic colitis: An under-recognized complication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33074881" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Comment on "Gastrointestinal Complications in Critically Ill Patients With COVID-19": An Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32363540" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Bowel Necrosis in the Setting of COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33072452" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Bowel Ischemia in a Patient With SARS CoV-2-Like Illness and Negative Real-Time Reverse Transcription Polymerase Chain Reaction Test Results During the Peak of the Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32351657" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Arterial and venous abdominal thrombosis in a 79-year-old woman with COVID-19 pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33083204" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Acute mesenteric thrombosis in two patients with COVID-19. Two cases report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32399456" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32532607" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Intestinal ischemia in the COVID-19 era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33341452" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32970653" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A 29-Year-Old Male Construction Worker from India Who Presented with Left- Sided Abdominal Pain Due to Isolated Superior Mesenteric Vein Thrombosis Associated with SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32720012" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Acute abdomen in patients with SARS-CoV-2 infection or co-infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32969365" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Acute Intestinal Ischemia in a Patient with COVID-19 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32506344" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Acute intestinal ischemia in a patient with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32954769" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Severe colon ischemia in patients with severe coronavirus-19 (COVID-19).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32396504" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Abdominal Visceral Infarction in 3 Patients with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32450607" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Gastrointestinal: Bowel ischemia in a suspected coronavirus disease (COVID-19) patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33146121" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Case Report: Ischemic Colitis in Severe COVID-19 Pneumonia: An Unforeseen Gastrointestinal Complication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32301807" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Emergency Surgery in Suspected COVID-19 Patients With Acute Abdomen: Case Series and Perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32538098" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Extensive pneumatosis intestinalis and portal venous gas mimicking mesenteric ischaemia in a patient with SARS-CoV-2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32985002" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Gastrointestinal: COVID-19 related ischemic bowel disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32391742" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Abdominal Imaging Findings in COVID-19: Preliminary Observations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33024534" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Case reports: mild COVID-19 infection and acute arterial thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32970139" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Gastrointestinal Complications in Critically Ill Patients With and Without COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32241899" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32890595" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : COVID-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33147641" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : SARS-CoV-2 in the bile of a patient with COVID-19-associated gallbladder disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32498972" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : SARS-CoV2 RNA detection in a pancreatic pseudocyst sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32235945" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Virological assessment of hospitalized patients with COVID-2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32015507" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A pneumonia outbreak associated with a new coronavirus of probable bat origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32311451" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32511375" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A single-cell RNA expression map of human coronavirus entry factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33336018" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32334082" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32715618" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The protein expression profile of ACE2 in human tissues.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
